Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
Jane A. Leopold, Bradley A. Maron
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 5, pp. 761-761
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Endothelial Cell Metabolism
Guy Eelen, Pauline de Zeeuw, Lucas Treps, et al.
Physiological Reviews (2017) Vol. 98, Iss. 1, pp. 3-58
Open Access | Times Cited: 448
Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis
Hui Zhang, Daren Wang, Min Li, et al.
Circulation (2017) Vol. 136, Iss. 25, pp. 2468-2485
Open Access | Times Cited: 209
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
Metabolic reprogramming, oxidative stress, and pulmonary hypertension
Marissa D. Pokharel, David Marciano, Panfeng Fu, et al.
Redox Biology (2023) Vol. 64, pp. 102797-102797
Open Access | Times Cited: 51
Endothelial HIF-2α Contributes to Severe Pulmonary Hypertension by Inducing Endothelial-to-Mesenchymal Transition
Haiyang Tang, Aleksandra Babicheva, Kimberly M. McDermott, et al.
AJP Lung Cellular and Molecular Physiology (2017), pp. ajplung.00096.2-ajplung.00096.2
Open Access | Times Cited: 165
Metabolic Pathways Fueling the Endothelial Cell Drive
Xuri Li, Anil Kumar, Peter Carmeliet
Annual Review of Physiology (2019) Vol. 81, Iss. 1, pp. 483-503
Closed Access | Times Cited: 131
Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension
Toshio Suzuki, Erica J. Carrier, Megha Talati, et al.
AJP Lung Cellular and Molecular Physiology (2017) Vol. 314, Iss. 1, pp. L118-L126
Open Access | Times Cited: 90
Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both
Jeffrey D. Marshall, Isabel Bazán, Yi Zhang, et al.
AJP Lung Cellular and Molecular Physiology (2018) Vol. 314, Iss. 5, pp. L782-L796
Open Access | Times Cited: 87
Vimentin regulates Notch signaling strength and arterial remodeling in response to hemodynamic stress
Nicole C. A. van Engeland, Freddy Suarez Rodriguez, Adolfo Rivero‐Müller, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 78
Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension
Dan Xu, Ya‐Hui Hu, Xue Gou, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3724-3724
Open Access | Times Cited: 43
New Drugs and Therapies in Pulmonary Arterial Hypertension
Aangi J. Shah, Taylor Beckmann, Mounica Vorla, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5850-5850
Open Access | Times Cited: 35
Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review
Jinjing Zhang, Mao-mao, Minmin Shao, et al.
Phytomedicine (2024) Vol. 128, pp. 155535-155535
Closed Access | Times Cited: 11
o 8 G Site-Specifically Modified tRF-1-AspGTC: A Novel Therapeutic Target and Biomarker for Pulmonary Hypertension
Junting Zhang, Yiying Li, Yuan Chen, et al.
Circulation Research (2024) Vol. 135, Iss. 1, pp. 76-92
Closed Access | Times Cited: 9
Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling
Jingjing Zhang, X. Ye, Xuesong Liu, et al.
World Journal of Cardiology (2025) Vol. 17, Iss. 1
Closed Access | Times Cited: 1
Dysfunction in mitochondrial electron transport chain drives the pathogenesis of pulmonary arterial hypertension: insights from a multi-omics investigation
Xin Zhang, Jieling Li, Minyi Fu, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access | Times Cited: 1
HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension
Olivier Boucherat, Sophie Chabot, Roxane Paulin, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 87
Endothelial-to-mesenchymal transition: A novel therapeutic target for cardiovascular diseases
Ampadu O. Jackson, Jingjing Zhang, Zhi‐Sheng Jiang, et al.
Trends in Cardiovascular Medicine (2017) Vol. 27, Iss. 6, pp. 383-393
Closed Access | Times Cited: 82
Circ- calm4 Serves as an miR-337-3p Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation
Junting Zhang, Yiying Li, Jing Qi, et al.
Hypertension (2020) Vol. 75, Iss. 3, pp. 668-679
Open Access | Times Cited: 58
mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
Aleksandra Babicheva, Ayako Makino, Jason X.‐J. Yuan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2144-2144
Open Access | Times Cited: 43
The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
Inés Roger, Javier Milara, Paula Montero, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4980-4980
Open Access | Times Cited: 42
Molecular Pathways in Pulmonary Arterial Hypertension
Aangi J. Shah, Mounica Vorla, Dinesh Kalra
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10001-10001
Open Access | Times Cited: 37
Molecular regulation and therapeutic implications of cell death in pulmonary hypertension
Enze Wang, Sijing Zhou, Daxiong Zeng, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 18
Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
Mario Boehm, Nadine Arnold, Adam Braithwaite, et al.
BMC Pulmonary Medicine (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 55
Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis
Roberto Badagliacca, Franz Rischard, Silvia Papa, et al.
The Journal of Heart and Lung Transplantation (2020) Vol. 39, Iss. 4, pp. 310-320
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top